Related references
Note: Only part of the references are listed.Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly
Yu Bin Seo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine
Harshad P. Patil et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Lanying Du et al.
JOURNAL OF VIROLOGY (2014)
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice
G. Pineton de Chambrun et al.
MUCOSAL IMMUNOLOGY (2014)
Calling for rapid development of a safe and effective MERS vaccine
Peter J. Hotez et al.
MICROBES AND INFECTION (2014)
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Esam I. Azhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus
Yang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
Cuiqing Ma et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
Detection of the Middle East Respiratory Syndrome Coronavirus Genome in an Air Sample Originating from a Camel Barn Owned by an Infected Patient
Esam I. Azhar et al.
MBIO (2014)
Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia
Thomas Briese et al.
MBIO (2014)
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials
Odile Launay et al.
BMC INFECTIOUS DISEASES (2013)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
Christopher B. Fox et al.
EXPERT REVIEW OF VACCINES (2013)
Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells
Xinrong Tao et al.
JOURNAL OF VIROLOGY (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
Lu Lu et al.
MICROBES AND INFECTION (2013)
A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection
Lanying Du et al.
PLOS ONE (2013)
Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice
Julie Todoroff et al.
PLOS ONE (2013)
A Prime-Pull Vaccine Strategy Has a Modest Effect on Local and Systemic Antibody Responses to HIV gp140 in Mice
John S. Tregoning et al.
PLOS ONE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind randomised placebo-controlled study
Lynette Denny et al.
VACCINE (2013)
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
Ziad A. Memish et al.
EMERGING INFECTIOUS DISEASES (2013)
Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa
Ndapewa Laudika Ithete et al.
EMERGING INFECTIOUS DISEASES (2013)
Safety and Immunogenicity of Multimeric-001-a Novel Universal Influenza Vaccine
Jacob Atsmon et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Evidence for a Common Evolutionary Origin of Coronavirus Spike Protein Receptor-Binding Subunits
Fang Li
JOURNAL OF VIROLOGY (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Adjuvanticity of an O-volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
Jing Wang et al.
PLOS ONE (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Developments of subunit and VLP vaccines against influenza a virus
Ma-ping Deng et al.
VIROLOGICA SINICA (2012)
Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine
Hee Jin Cheong et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers
Paul Spearman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Human IgG Subclasses: In Vitro Neutralization of and In Vivo Protection against West Nile Virus
Yvonne Hofmeister et al.
JOURNAL OF VIROLOGY (2011)
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses
Lanying Du et al.
PLOS ONE (2011)
Vaccine adjuvants - Current status and prospects on controlled release adjuvancity
S. M. Sivakumar et al.
SAUDI PHARMACEUTICAL JOURNAL (2011)
Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems
Camilla Foged
THERAPEUTIC DELIVERY (2011)
Mode of action of adjuvants: Implications for vaccine safety and design
Béatris Mastelic et al.
BIOLOGICALS (2010)
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly
Elena Fragapane et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
New adjuvants for human vaccines
M. Lamine Mbow et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
Paolo Durando et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
David J. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The immunobiology of aluminium adjuvants: how do they really work?
Christopher Exley et al.
TRENDS IN IMMUNOLOGY (2010)
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates
Filippo Ansaldi et al.
VACCINE (2010)
Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors
John C. Martyn et al.
ARCHIVES OF VIROLOGY (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
Lanying Du et al.
VIROLOGY (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
C. R. Casella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Molecular and cellular signatures of human vaccine adjuvants
F. Mosca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
Veronica Mata-Haro et al.
SCIENCE (2007)
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Hongying Chen et al.
RETROVIROLOGY (2007)
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Lanying Du et al.
VACCINE (2007)
Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein
Yuxian He et al.
JOURNAL OF IMMUNOLOGY (2006)
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
NS Zhong et al.
LANCET (2003)
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
R Gasparini et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
Share Paper
